AAAAAA

   
Results: 1-9 |
Results: 9
Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma
Authors: Lillington, DM Micallef, INM Carpenter, E Neat, MJ Amess, JAL Matthews, J Foot, NJ Young, BD Lister, TA Rohatiner, AZS
Citation: Dm. Lillington et al., Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma, J CL ONCOL, 19(9), 2001, pp. 2472-2481
Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis
Authors: Foran, JM Norton, AJ Micallef, INM Taussig, DC Amess, JAL Rohatiner, AZS Lister, TA
Citation: Jm. Foran et al., Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis, BR J HAEM, 114(4), 2001, pp. 881-883
Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia
Authors: Micallef, INM Rohatiner, AZS Carter, M Boyle, M Slater, S Amess, JAL Lister, TA
Citation: Inm. Micallef et al., Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia, BR J HAEM, 113(2), 2001, pp. 443-445
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma
Authors: Porrata, LF Gertz, MA Inwards, DJ Litzow, MR Lacy, MQ Tefferi, A Gastineau, DA Dispenzieri, A Ansell, SM Micallef, INM Geyer, SM Markovic, SN
Citation: Lf. Porrata et al., Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma, BLOOD, 98(3), 2001, pp. 579-585
Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide
Authors: Jenner, MJ Micallef, INM Rohatiner, AZ Kelsey, SM Newland, AC Cavenagh, JD
Citation: Mj. Jenner et al., Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide, MED ONCOL, 17(4), 2000, pp. 333-336
A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma
Authors: Crawley, CR Foran, JM Gupta, RK Rohatiner, AZS Summers, K Matthews, J Micallef, INM Radford, JA Johnson, SA Johnson, PW Sweetenham, JW Lister, TA
Citation: Cr. Crawley et al., A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma, ANN ONCOL, 11(7), 2000, pp. 861-865
Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell supportfor lymphoid malignancies
Authors: Micallef, INM Lillington, DM Apostolidis, J Amess, JAL Neat, M Matthews, J Clark, T Foran, JM Salam, A Lister, TA Rohatiner, AZS
Citation: Inm. Micallef et al., Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell supportfor lymphoid malignancies, J CL ONCOL, 18(5), 2000, pp. 947-955
Peripheral T-cell lymphoma following Rituximab therapy for B-cell lymphoma
Authors: Micallef, INM Kirk, A Norton, A Foran, JM Rohatiner, AZS Lister, TA
Citation: Inm. Micallef et al., Peripheral T-cell lymphoma following Rituximab therapy for B-cell lymphoma, BLOOD, 93(7), 1999, pp. 2427-2428
Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience
Authors: Micallef, INM Chhanabhai, M Gascoyne, RD Shepherd, JD Fung, HC Nantel, SH Toze, CL Klingemann, HG Sutherland, HJ Hogge, DE Nevill, TJ Le, A Barnett, MJ
Citation: Inm. Micallef et al., Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience, BONE MAR TR, 22(10), 1998, pp. 981-987
Risultati: 1-9 |